Multispecific chimeric receptors

• US 6,103,521 A
• Filed: 05/30/1995
• Issued: 08/15/2000
• Est. Priority Date: 02/06/1995
• Status: Expired due to Fees

• Current Assignee: Cell Genesys Incorporated (ANI Pharmaceuticals, Inc.)
• Original Assignee: Cell Genesys Incorporated (ANI Pharmaceuticals, Inc.)
• Inventors: Smith, Douglas H., Capon, Daniel J., Tian, Huan, Siekevitz, Miriam, Winslow, Genine A.
• Primary Examiner(s): Caputa, Anthony C.
• Assistant Examiner(s): PAK, MICHAEL D
• Application Number:
  US08/454,098
• Time in Patent Office: 1,904 Days
• Field of Search: 536/23.4, 435/69.1, 435/240.2, 435/252.3, 435/320.1, 435/325, 435/69.7, 530/350, 530/351, 530/387.1, 530/387.3
• US Class Current: 435/325
• CPC Class Codes: A61K 2039/505 comprising antibodies
• CPC Class Codes: A61K 39/4611 T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
• CPC Class Codes: A61K 39/4631 Chimeric Antigen Receptors [CAR]
• CPC Class Codes: A61K 39/464838 Viral antigens
• CPC Class Codes: C07K 14/005 from viruses
• CPC Class Codes: C07K 14/7051 T-cell receptor (TcR)-CD3 complex
• CPC Class Codes: C07K 14/70514 CD4
• CPC Class Codes: C07K 16/1063 env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
• CPC Class Codes: C07K 2317/24 containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
• CPC Class Codes: C07K 2317/31 multispecific
• CPC Class Codes: C07K 2317/622 Single chain antibody (scFv)
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C07K 2319/02 containing a signal sequence
• CPC Class Codes: C12N 2740/10043 viral genome or elements thereof as genetic vector
• CPC Class Codes: C12N 2740/16122 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Novel multispecific chimeric receptor DNA sequences, expression cassettes and vectors containing these sequences as well as cells containing the chimeric DNA and novel chimeric receptor proteins expressed from the sequences are provided in the present invention. The novel multispecific chimeric receptor DNA and amino acid sequences comprise at least three domains that do not naturally exist together: (1) a multispecific binding domain comprising at least two extracellular inducer-responsive clustering domains which serves to bind at least one specific inducer molecule, (2) a transmembrane domain, which crosses the plasma membrane, and (3) either a proliferation signaling domain that signals the cell to divide, or an effector function signaling domain which directs a host cell to perform its specialized function. Optionally, all the multispecific chimeric receptors may contain one or more intracellular inducer-responsive clustering domains attached to one or more of the cytoplasmic signaling domains or the transmembrane domain. The present invention also relates to novel hybrid multispecific chimeric receptors comprising at least one proliferation signaling domain and at least one effector function signaling domain together on the multispecific receptor molecule. The present invention further relates to therapeutic methods and strategies that employ the cells expressing these novel chimeric receptors for the treatment of cancer, infectious disease and autoimmune disease which may have greater therapeutic benefit over a combination of drug therapies.

Claims

1. A DNA molecule encoding a chimeric membrane bound protein, said protein comprising in the N-terminal to C-terminal direction:

at least two extracellular inducer-responsive clustering domains in tandem to form a multispecific extracellular inducer-responsive clustering domain that binds specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain; and

a cytoplasmic signaling domain comprising a ζ

or η

chain of the T-cell receptor, or a Janus kinase,

wherein when said membrane bound protein is expressed in a selected host cell under conditions suitable for expression, said membrane bound protein initiates a signal in said host cell on binding to said at least one inducer molecule.

2. The DNA molecule according to claim 1 wherein at least one said extracellular inducer responsive clustering domain is an antibody or single-chain antibody or portions or modifications thereof containing inducer binding and clustering activity.

3. The DNA molecule according to claim 2 wherein at least one said extracellular inducer responsive clustering domain is a cell differentiation antigen.

4. The DNA molecule according to claim 1 wherein at least one said extracellular inducer-responsive clustering domain is CD4 and at least another said extracellular inducer-responsive clustering domain is an antibody or single chain antibody.

5. The DNA molecule according to claim 2 wherein at least one said antibody or single chain antibody recognizes an antigen from a virus selected from the group consisting of HIV, hepatitis A, B and C viruses, Kaposi'"'"'s sarcoma associated Herpes virus, Herpes Simplex viruses, Herpes Zoster virus, cytomegalovirus, papilloma virus, respiratory syncytial virus and influenza virus.

6. The DNA molecule according to claim 2 wherein at least one said antibody or said single chain antibody recognizes an antigen on a cancer cell selected from the group consisting of interleukin 14 receptor, CD19, CD20, Lewis Y antigen, CEA, Tag72 antigen, EGF-R and HER-2.

7. The DNA molecule according to claim 1 wherein said transmembrane domain is naturally associated with one of said extracellular inducer responsive clustering domains.

8. The DNA molecule according to claim 1 wherein said transmembrane domain is naturally associated with said signaling domain.

25. An expression cassette comprising a transcriptional initiation region, a DNA molecule according to claim 1 under the transcriptional control of said transcriptional initiation region and a transcriptional termination region.

30. The expression cassette according to claim 25, 26, 27, 28 or 29 wherein said transcriptional initiation region is functional in a mammalian host.

31. A cell comprising a DNA molecule according to claim 1.

36. A cell comprising an DNA molecule that encodes a chimeric effector function receptor comprising an extracellular inducer-responsive clustering domain, a transmembrane domain, and a effector function signaling domain and further comprising a second DNA molecule according to claim 1.

41. The cell according to claim 31, 32, 33, 34, 35, 36, 37 or 39, wherein said cell is a mammalian cell.

42. The cell according to claim 31, 32, 33, 34, 35, 36, 37 or 39, wherein said cell is a human cell.

9. A DNA molecule encoding a chimeric membrane bound protein, said chimeric protein comprising in the N-terminal to C-terminal direction:

at least two extracellular inducer-responsive clustering domains in tandem to form a multispecific extracellular inducer-responsive clustering domain that binds specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising a Janus kinase; and

a cytoplasmic domain comprising ζ

or η

chain of the T-cell receptor;

wherein when said membrane bound protein is expressed in a selected host cell under conditions suitable for expression, said membrane bound protein initiates a signal for proliferation and effector function in said host cell on binding to said at least one inducer molecule.

15. The DNA molecule according to claim 9, wherein at least one said single chain antibody recognizes an antigen on a cancer cell selected from the group consisting of interleukin 14 receptor, CD19, CD20, Lewis Y antigen, CEA, Tag72 antigen, EGF-R and HER-2.

17. The DNA molecule according to claim 9, wherein said transmembrane domain is naturally associated with one of said multispecific extracellular inducer-responsive clustering domains.

26. An expression cassette comprising a transcriptional initiation region, a DNA molecule according to claim 9 under the transcriptional control of said transcriptional initiation region and a transcriptional termination region.

32. A cell comprising a DNA molecule according to claim 9.

37. A cell comprising a DNA molecule that encodes a chimeric effector function receptor comprising an extracellular inducer-responsive clustering domain, a transmembrane domain, and a effector function signaling domain, and further comprising a second DNA molecule according to claim 9.

10. A DNA molecule encoding a chimeric membrane bound protein, said chimeric protein comprising in the N-terminal to C-terminal direction:

at least two extracellular inducer-responsive clustering domains in tandem to form a multispecific extracellular inducer-responsive clustering domain that binds specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising ζ

or η

chain of the T-cell receptor; and

a cytoplasmic domain comprising a Janus kinase;

wherein when said membrane bound protein is expressed in a selected host cell under conditions suitable for expression, said membrane bound protein initiates a signal for proliferation and effector function in said host cell on binding to said at least one inducer molecule.

11. The DNA molecule according to claim 9 or 10, wherein at least one said extracellular inducer responsive clustering domain is an antibody or single-chain antibody or portions or modifications thereof containing inducer binding and clustering activity.

12. The DNA molecule according to claim 9 or 10, wherein at least one said extracellular inducer responsive clustering domain is a cell differentiation antigen.

13. The DNA molecule according to claim 9 or 10, wherein at least one said extracellular inducer-responsive clustering domain is CD4 and at least one other said extracellular inducer-responsive clustering domain is a single chain antibody.

14. The DNA molecule according to claim 11, wherein at least one said single chain antibody recognizes an antigen from a virus selected from the group consisting of HIV, hepatitis A, B and C viruses, Kaposi'"'"'s sarcoma associated Herpes virus, Herpes Simplex viruses, Herpes Zoster virus, cytomegalovirus, respiratory syncytial virus, influenza virus and papilloma virus.

16. The DNA molecule according to claim 10, wherein said transmembrane domain is naturally associated with one of said multispecific extracellular inducer-responsive clustering domains, or ζ

or η

chain of the T-cell receptor.

27. An expression cassette comprising a transcriptional initiation region, a DNA molecule according to claim 10 under the transcriptional control of said transcriptional initiation region and a transcriptional termination region.

33. A cell comprising a DNA molecule according to claim 10.

38. The cell comprising a DNA molecule that encodes a chimeric receptor comprising an extracellular inducer-responsive clustering domain, a transmembrane domain, a transmembrane domain and an effector function signaling domain, and a second DNA molecule according to claim 10.

18. A DNA molecule encoding a hybrid extracellular and intracellular multispecific chimeric receptor protein, said chimeric protein comprising in the N-terminal to C-terminal direction:

at least two extracellular inducer-responsive clustering domains in tandem to form a multispecific extracellular inducer-responsive clustering domain that binds specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising a Janus kinase; and

an intracellular inducer-responsive clustering domain comprising an immunophilin or a cyclophilin;

wherein when said chimeric receptor protein is expressed in a selected host cell under conditions suitable for expression, said receptor protein initiates a signal for proliferation in said host cell on binding to said at least one inducer molecule.

19. The DNA of claim 18, wherein at least one said extracellular clustering domains is an antibody or single-chain antibody or portions or modifications thereof containing inducer binding and clustering antibody.

20. The DNA of claim 18, wherein at least one said extracellular clustering domains is a cell differentiation antigen.

24. The DNA molecule according to claim 18 or 21, wherein said intracellular inducer responsive clustering domain binds to a natural or synthetic inducer that is cell membrane permeable and induces the clustering of said intracellular inducer responsive domain.

28. An expression cassette comprising a transcriptional initiation region, a DNA molecule according to claim 18 under the transcriptional control of said transcriptional initiation region and a transcriptional termination region.

34. A cell comprising a DNA molecule according to claim 18.

39. A cell comprising a DNA molecule that encodes a chimeric effector function receptor comprising an extracellular inducer-responsive clustering domain, a transmembrane domain, and an effector function signaling domain, and further comprising a second DNA molecule according to claim 18.

21. A DNA molecule encoding a hybrid multispecific chimeric receptor protein, said protein comprising in the N-terminal to C-terminal direction:

at least two extracellular inducer-responsive clustering domains in tandem to form a multispecific extracellular inducer-responsive clustering domain that binds specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising a Janus kinase;

a cytoplasmic domain comprising a ζ

or η

chain of the T-cell receptor; and

an intracellular inducer-responsive clustering domain comprising an immunophilin or a cyclophilin;

wherein when said hybrid multispecific chimeric receptor is expressed in a selected host cell under conditions suitable for expression, said receptor protein initiates a signal for proliferation and effector function in said host cell on binding to said at least one inducer molecule.

22. The DNA of claim 21, wherein at least one said extracellular clustering domains is an antibody or single-chain antibody or portions or modifications thereof containing inducer binding and clustering activity.

23. The DNA of claim 21, wherein at least one said extracellular clustering domains is a cell differentiation antigen.

29. An expression cassette comprising a transcriptional initiation region, a DNA molecule according to claim 21 under the transcriptional control of said transcriptional initiation region and a transcriptional termination region.

35. A cell comprising a DNA molecule according to claim 21.

40. The cell comprising a DNA molecule that encodes a chimeric receptor comprising an extracellular inducer-responsive clustering domain, a transmembrane domain, a transmembrane domain and an effector function signaling domain, and a second DNA molecule according to claim 21.

43. A chimeric protein comprising in the N-terminal to C-terminal direction:

a multispecific extracellular inducer-responsive clustering domain comprising at least two domains in tandem that bind specifically to at least one inducer-molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain; and

a cytoplasmic domain comprising a ζ

or η

chain of the T-cell receptor, or a Janus kinase;

wherein when said chimeric protein is expressed as a membrane bound protein in a selected host cell under conditions suitable for expression, said membrane bound protein initiates a signal in said host cell on binding to said at least one inducer molecule.

44. A chimeric protein comprising in the N-terminal to C-terminal direction:

a multispecific extracellular inducer-responsive clustering domain comprising at least two domains in tandem that bind specifically to at least one inducer-molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising a Janus kinase; and

a cytoplasmic domain comprising ζ

or η

;

wherein when said chimeric protein is expressed as a membrane bound protein in a selected host cell under conditions suitable for expression, said membrane bound protein initiates a signal for proliferation and effector function in said host cell on binding to said at least one inducer molecule.

45. A chimeric protein comprising in the N-terminal to C-terminal direction:

a multispecific extracellular inducer-responsive clustering domain comprising at least two domains in tandem that bind specifically to at least one inducer-molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising ζ

or η

chain of the T-cell receptor; and

a cytoplasmic domain comprising a Janus kinase;

wherein when said chimeric protein is expressed as a membrane bound protein in a selected host cell under conditions suitable for expression, said membrane bound protein initiates a signal for proliferation and effector function in said host cell on binding to said at least one inducer molecule.

46. A chimeric hybrid binding protein comprising in the N-terminal to C-terminal direction:

a multispecific extracellular inducer-responsive clustering domain comprising at least two domains in tandem that bind specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising a Janus kinase; and

an intracellular inducer-responsive clustering domain comprising an immunophilin or a cyclophilin;

wherein when said chimeric hybrid binding protein is expressed as a protein receptor in a selected host cell under conditions suitable for expression, said protein receptor initiates a signal for proliferation in said host cell on binding to either said inducer molecule or combinations thereof.

47. A chimeric hybrid binding protein comprising in the N-terminal to C-terminal direction:

a multispecific extracellular inducer-responsive clustering domain comprising at least two domains in tandem that bind specifically to at least one inducer molecule which results in the dimerization or oligomerization of said multispecific extracellular domain;

a transmembrane domain;

a cytoplasmic domain comprising a Janus kinase;

a cytoplasmic domain comprising ζ

or η

chain of the T-cell receptor; and

an intracellular inducer-responsive clustering domain comprising an immunophilin or a cyclophilin;

wherein when said chimeric hybrid binding protein is expressed as a protein receptor in a selected host cell under conditions suitable for expression, said protein receptor initiates a signal for proliferation in said host cell on binding to either said inducer molecule or combinations thereof.